CG Oncology (CGON) Revenue (2023 - 2026)

CG Oncology (CGON) has 4 years of Revenue data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Revenue rose 1982.69% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 666.01% YoY) and the FY2025 annual result came in at $4.0 million, up 254.7% from the prior year.
• Revenue fell to $1.1 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.3 million in Q4 2025 to a low of $1000.0 in Q4 2023.
• A 4-year average of $587818.2 and a median of $194000.0 in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2024 — Revenue jumped 45500.0% — and 2025, when it slumped 90.17%.
• Tracing CGON's Revenue over 4 years: stood at $1000.0 in 2023, then jumped by 45500.0% to $456000.0 in 2024, then jumped by 409.21% to $2.3 million in 2025, then sank by 53.36% to $1.1 million in 2026.
• The last three Revenue figures came in at $1.1 million (Q1 2026), $2.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.